Dianthus Therapeutics, Inc. (DNTH)
76.78
-1.75
(-2.23%)
USD |
NASDAQ |
Oct 23, 16:00
76.77
-0.01
(-0.01%)
After-Hours: 20:00
Dianthus Therapeutics Shareholders Equity (Quarterly) : 1.172B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.172B |
| March 31, 2026 | 1.201B |
| December 31, 2025 | 493.40M |
| September 30, 2025 | 546.45M |
| June 30, 2025 | 303.08M |
| March 31, 2025 | 328.61M |
| December 31, 2024 | 352.48M |
| September 30, 2024 | 337.90M |
| June 30, 2024 | 358.22M |
| March 31, 2024 | 372.69M |
| December 31, 2023 | 168.87M |
| September 30, 2023 | 178.38M |
| June 30, 2023 | 74.60M |
| March 31, 2023 | 77.46M |
| December 31, 2022 | 73.66M |
| September 30, 2022 | 124.02M |
| June 30, 2022 | 135.68M |
| March 31, 2022 | 151.19M |
| Date | Value |
|---|---|
| December 31, 2021 | 172.67M |
| September 30, 2021 | 189.69M |
| June 30, 2021 | 202.89M |
| March 31, 2021 | 129.06M |
| December 31, 2020 | 143.91M |
| September 30, 2020 | 158.57M |
| June 30, 2020 | 173.91M |
| March 31, 2020 | 125.40M |
| December 31, 2019 | 141.19M |
| September 30, 2019 | 161.53M |
| June 30, 2019 | 179.56M |
| March 31, 2019 | 134.00M |
| December 31, 2018 | 145.65M |
| September 30, 2018 | 159.78M |
| June 30, 2018 | 172.22M |
| March 31, 2018 | 40.58M |
| December 31, 2017 | 50.32M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem, Inc. | 49.99M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.213B |
| Total Liabilities (Quarterly) | 41.25M |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 26.10 |
| Net Debt Paydown Yield | 0.00% |